Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment
Crossref DOI link: https://doi.org/10.1136/bmjebm-2018-111145
Published Online: 2019-03-21
Published Print: 2019-10
Update policy: https://doi.org/10.1136/crossmarkpolicy
Baronikova, Slavka
Purvis, Jim
Southam, Eric
Beeso, Julie
Panayi, Antonia
Winchester, Christopher
Funding for this research was provided by:
Shire International GmbH
Oxford PharmaGenesis Ltd
